An interventional study of TECAR therapy and Sham TECAR therapy in Prostatitis, sponsored by Middle East University. Not yet recruiting at 1 site in Egypt. Open to male participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-01-07.
Sponsored by Middle East University · Not applicable, Interventional, and Treatment
Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.
Sixty men with chronic prostatitis/chronic pelvic pain will be sourced from the urology outpatient clinic at Tanta University hospitals in Egypt, with referrals from urologists. Patients will be randomly assigned into two groups.
Study group: It will include 30 men receiving true TECAR therapy plus dietary and life style adjustments.
Control group: It will include 30 men receiving sham TECAR therapy plus dietary and life style adjustments.
Evaluation Procedures:
88 studies on the registry are indexed under Prostatitis; 11 are open to participants now.
This study's planned enrollment of 60 is close to the median of 60 across 73 interventional studies indexed under Prostatitis.
Browse Prostatitis studies →Middle East University is the lead sponsor of 19 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: TECAR therapy
Device: Sham TECAR therapy
WINBACK 3SE (France) will be used for TECAR therapy in this study. To facilitate optimal distribution of endogenous heat therapy and effective contact between the active electrodes, both capacitive and resistive, and the surface of the skin, a layer of high-conductivity cream will be applied to the treatment region. The plate, an inactive electrode, which has a specific size (21cm\*15cm), will be placed on the gluteal region. The capacitive electrode was employed for a duration of seven and a half minutes, at an intensity of 30-40%, whereas the resistance electrode will be utilized for an equivalent period over the perineum at the same intensity.
The procedure is similar to the active treatment of TECAR, but with the critical difference being that the output intensity of the TECAR device will be set to zero during the session.
Pelvic pain
Pain will be assessed using the National Institutes of Health-Chronic Prostatitis Symptom Index
Time frame: Baseline and 8 weeks later
Quality of life of men
Quality of life will be assessed using the National Institutes of Health-Chronic Prostatitis Symptom Index
Time frame: Baseline and after 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2026; primary completion for Apr 2026, 2 months later.
Of 21 interventional studies with no phase under Prostatitis, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 25. This study's planned 2 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Middle East University